Inducible cyclooxygenase expression mediating hypoxia/reoxygenation-induced pulmonary vasoconstriction is attenuated by a cyclooxygenase inhibitor in rats

Chien-Ling Su, D. W. Yuan, L. L. Chiang, H. L. Lee, K. H. Chen, D. Wang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: Hypoxic pulmonary vasoconstriction (HPV) is a well known phenomenon to temporarily offset a ventilation-perfusion mismatch. Sustained HPV may lead to pulmonary hypertension. In this protocol, we studied the relationships between the HPV response and inducible cyclooxygenase II (COX II) activation after hypoxia-reoxygenation (H-R) challenge in an isolated perfused lung model. Methods: An in situ isolated perfused rat lung model underwent inaction of hypoxia by ventilation with 5% CO 2-95% N 2 for 10 minutes instead of 5% CO 2-95% air; they were then reoxygenated with 5% CO 2-95% air. We measured pulmonary arterial pressure (PAP) changes before, during, and after H-R challenge. We also estimated changes in blood concentrations of hydroxyl radicals, nitric oxide (NO) and thromboxane B 2 (TxB 2) before and after H-R as well as mRNA expressions of COX II in lung tissue thereafter. A COX II inhibitor, celecoxib (10 mg/kg), was administered between 2 consecutive challenges. Results: Hypoxia induced pulmonary vasoconstriction by increasing PAP (4.1 ± 0.8 mm Hg). Consecutive hypoxic challenges did not show tachyphylaxis (P >.05). H-R of lung tissues induced significant increases in blood concentrations of hydroxyl radicals (48.5 ± 7.6 vs 75.8 ± 11.5 mmol/L; P 2 (42.3 ± 6.9 vs 58.7 ± 8.6 pg/mL; P 2 (P 2 release.

Original languageEnglish
Pages (from-to)929-932
Number of pages4
JournalTransplantation Proceedings
Volume44
Issue number4
DOIs
Publication statusPublished - May 2012

Fingerprint

Cyclooxygenase Inhibitors
Prostaglandin-Endoperoxide Synthases
Vasoconstriction
Lung
Carbon Monoxide
Celecoxib
Hydroxyl Radical
Ventilation
Arterial Pressure
Air
Hypoxia
Tachyphylaxis
Thromboxanes
Pulmonary Hypertension
Nitric Oxide
Perfusion
Messenger RNA

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Inducible cyclooxygenase expression mediating hypoxia/reoxygenation-induced pulmonary vasoconstriction is attenuated by a cyclooxygenase inhibitor in rats. / Su, Chien-Ling; Yuan, D. W.; Chiang, L. L.; Lee, H. L.; Chen, K. H.; Wang, D.

In: Transplantation Proceedings, Vol. 44, No. 4, 05.2012, p. 929-932.

Research output: Contribution to journalArticle

Su, Chien-Ling ; Yuan, D. W. ; Chiang, L. L. ; Lee, H. L. ; Chen, K. H. ; Wang, D. / Inducible cyclooxygenase expression mediating hypoxia/reoxygenation-induced pulmonary vasoconstriction is attenuated by a cyclooxygenase inhibitor in rats. In: Transplantation Proceedings. 2012 ; Vol. 44, No. 4. pp. 929-932.
@article{05c7584dca454b54895f46f7ff3873fe,
title = "Inducible cyclooxygenase expression mediating hypoxia/reoxygenation-induced pulmonary vasoconstriction is attenuated by a cyclooxygenase inhibitor in rats",
abstract = "Objective: Hypoxic pulmonary vasoconstriction (HPV) is a well known phenomenon to temporarily offset a ventilation-perfusion mismatch. Sustained HPV may lead to pulmonary hypertension. In this protocol, we studied the relationships between the HPV response and inducible cyclooxygenase II (COX II) activation after hypoxia-reoxygenation (H-R) challenge in an isolated perfused lung model. Methods: An in situ isolated perfused rat lung model underwent inaction of hypoxia by ventilation with 5{\%} CO 2-95{\%} N 2 for 10 minutes instead of 5{\%} CO 2-95{\%} air; they were then reoxygenated with 5{\%} CO 2-95{\%} air. We measured pulmonary arterial pressure (PAP) changes before, during, and after H-R challenge. We also estimated changes in blood concentrations of hydroxyl radicals, nitric oxide (NO) and thromboxane B 2 (TxB 2) before and after H-R as well as mRNA expressions of COX II in lung tissue thereafter. A COX II inhibitor, celecoxib (10 mg/kg), was administered between 2 consecutive challenges. Results: Hypoxia induced pulmonary vasoconstriction by increasing PAP (4.1 ± 0.8 mm Hg). Consecutive hypoxic challenges did not show tachyphylaxis (P >.05). H-R of lung tissues induced significant increases in blood concentrations of hydroxyl radicals (48.5 ± 7.6 vs 75.8 ± 11.5 mmol/L; P 2 (42.3 ± 6.9 vs 58.7 ± 8.6 pg/mL; P 2 (P 2 release.",
author = "Chien-Ling Su and Yuan, {D. W.} and Chiang, {L. L.} and Lee, {H. L.} and Chen, {K. H.} and D. Wang",
year = "2012",
month = "5",
doi = "10.1016/j.transproceed.2012.03.005",
language = "English",
volume = "44",
pages = "929--932",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Inducible cyclooxygenase expression mediating hypoxia/reoxygenation-induced pulmonary vasoconstriction is attenuated by a cyclooxygenase inhibitor in rats

AU - Su, Chien-Ling

AU - Yuan, D. W.

AU - Chiang, L. L.

AU - Lee, H. L.

AU - Chen, K. H.

AU - Wang, D.

PY - 2012/5

Y1 - 2012/5

N2 - Objective: Hypoxic pulmonary vasoconstriction (HPV) is a well known phenomenon to temporarily offset a ventilation-perfusion mismatch. Sustained HPV may lead to pulmonary hypertension. In this protocol, we studied the relationships between the HPV response and inducible cyclooxygenase II (COX II) activation after hypoxia-reoxygenation (H-R) challenge in an isolated perfused lung model. Methods: An in situ isolated perfused rat lung model underwent inaction of hypoxia by ventilation with 5% CO 2-95% N 2 for 10 minutes instead of 5% CO 2-95% air; they were then reoxygenated with 5% CO 2-95% air. We measured pulmonary arterial pressure (PAP) changes before, during, and after H-R challenge. We also estimated changes in blood concentrations of hydroxyl radicals, nitric oxide (NO) and thromboxane B 2 (TxB 2) before and after H-R as well as mRNA expressions of COX II in lung tissue thereafter. A COX II inhibitor, celecoxib (10 mg/kg), was administered between 2 consecutive challenges. Results: Hypoxia induced pulmonary vasoconstriction by increasing PAP (4.1 ± 0.8 mm Hg). Consecutive hypoxic challenges did not show tachyphylaxis (P >.05). H-R of lung tissues induced significant increases in blood concentrations of hydroxyl radicals (48.5 ± 7.6 vs 75.8 ± 11.5 mmol/L; P 2 (42.3 ± 6.9 vs 58.7 ± 8.6 pg/mL; P 2 (P 2 release.

AB - Objective: Hypoxic pulmonary vasoconstriction (HPV) is a well known phenomenon to temporarily offset a ventilation-perfusion mismatch. Sustained HPV may lead to pulmonary hypertension. In this protocol, we studied the relationships between the HPV response and inducible cyclooxygenase II (COX II) activation after hypoxia-reoxygenation (H-R) challenge in an isolated perfused lung model. Methods: An in situ isolated perfused rat lung model underwent inaction of hypoxia by ventilation with 5% CO 2-95% N 2 for 10 minutes instead of 5% CO 2-95% air; they were then reoxygenated with 5% CO 2-95% air. We measured pulmonary arterial pressure (PAP) changes before, during, and after H-R challenge. We also estimated changes in blood concentrations of hydroxyl radicals, nitric oxide (NO) and thromboxane B 2 (TxB 2) before and after H-R as well as mRNA expressions of COX II in lung tissue thereafter. A COX II inhibitor, celecoxib (10 mg/kg), was administered between 2 consecutive challenges. Results: Hypoxia induced pulmonary vasoconstriction by increasing PAP (4.1 ± 0.8 mm Hg). Consecutive hypoxic challenges did not show tachyphylaxis (P >.05). H-R of lung tissues induced significant increases in blood concentrations of hydroxyl radicals (48.5 ± 7.6 vs 75.8 ± 11.5 mmol/L; P 2 (42.3 ± 6.9 vs 58.7 ± 8.6 pg/mL; P 2 (P 2 release.

UR - http://www.scopus.com/inward/record.url?scp=84860780283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860780283&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2012.03.005

DO - 10.1016/j.transproceed.2012.03.005

M3 - Article

C2 - 22564588

AN - SCOPUS:84860780283

VL - 44

SP - 929

EP - 932

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 4

ER -